[{"NetIncomeLossConverted_1_Q1_USD":-26525000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":45311000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":55359000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.59,"CommonStockSharesOutstanding_0_Q1_shares":45377715.0,"StockholdersEquity_0_Q1_USD":1307522000.0,"RevenuesConverted_1_Q1_USD":252585000.0,"Assets_0_Q1_USD":1458394000.0,"CommonStockSharesConverted_0_Q1_shares":48070443.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":45311000.0,"EarningsPerShareBasic_1_Q1_USD":-0.59,"Ticker":"ABMD","CIK":"815094","name":"ABIOMED INC","OfficialName":"ABIOMED Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2022.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"14720849404.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"SP500","filed":"20210805"}]